RESEARCH-USE BIOSIMILAR ANTIBODY
Larcaviximab
Monoclonal antibody · IgG1
Larcaviximab (c4G7-N) is an IgG1 kappa chimeric monoclonal antibody against Ebola virus glycoprotein, which is applicable to studies related to Ebola virus infection.
TARGETZaire Ebolavirus GP
YMonoclonal antibody
CATALOGSC-BS-449
CATALOG NUMBERSC-BS-449
MOLECULAR WEIGHTApprox. 144.96 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Larcaviximab (c4G7-N) is an IgG1 kappa chimeric monoclonal antibody against Ebola virus glycoprotein, which is applicable to studies related to Ebola virus infection.
Larcaviximab is a recombinant research-use antibody directed against Zaire Ebolavirus GP.